Clinical trial
Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability…
NCT00384579 · United States Department of Defense, U.S. Fed · Terminated
Key facts
| NCT number | NCT00384579 |
|---|---|
| Title | Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain |
| Official title | Pilot Study to Assess the Efficacy of Botulinum Toxin B (Myobloc®) Treatment of Paravertebral Muscles on Pain and Disability in Subjects Suffering From Acute Low Back Pain |
| Lead sponsor | United States Department of Defense, U.S. Fed |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Low Back Pain |
| Intervention type | Drug |
| Interventions | Botulinum toxin B, Placebo |
| Enrollment | 0 |
| Start date | Feb 1, 2008 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Oct 6, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: